Objectives
Animal studies support a role for the gut microbiota in hypertension development, but large human studies are lacking. Here we investigated the relationship between hypertension prevalence and gut microbial composition in two cohorts.
Methods
We included 871 unrelated TwinsUK females with faecal microbiome data (16s rRNA gene sequencing). Multivariable linear models adjusted for age, age
2
and BMI as well as MiRKAT models, were used to estimate the association of hypertension with alpha- and beta-diversity metrics. To identify taxa associated with hypertension, a generalized additive model for location scale and shape was computed adjusting for covariates and multiple testing. Results were replicated in 448 women from PREDICT-1
Results
We found that measures of alpha diversity are significantly lower in hypertensive cases (Beta[95%CI] = -0.05[-0.095, -0.004], p=0.03) and a significant association between beta diversity and hypertension (FDR < 0.05). We identified and replicated 2 genera associated with hypertension. The genus,
Ruminiclostridium 6
was less abundant in hypertension cases (meta-analysis[95%CI] = -0.31[-0.5; -0.13], p = 1x10
-3
). The uncultured microbe
Erysipelotrichacea-UCG003
was more abundant in hypertensive cases (meta-analysis[95%CI] = 0.46[0.3, 0.62], p=1x10
-4
). We genomically analysed the 16s rRNA sequence and established a 100% identity match with the 16s rRNA sequence of the genus
Faecalibacillus
. We functionally annotated
Ruminiclostridium
, identifying 83 metabolic pathways, including pathways previously linked to blood pressure regulation.
Conclusion
In this large human observation, we show that gut microbiome diversity and composition are associated with hypertension. Our results suggest that targeting the microbiome may be a novel means to prevent or treat hypertension.